M. Mason

发表

Accuracy of patient positioning during radiotherapy for bladder and brain tumours.

N G Burnet, N. Burnet, C. L. Hanna, 1999, Clinical oncology (Royal College of Radiologists (Great Britain)).

The aetiology and pathogenesis of prostate cancer.

M. Mason, K. Rowley, M. Mason, 1997, Clinical oncology (Royal College of Radiologists (Great Britain)).

Intra-arterial adriamycin, conventionally fractionated radiotherapy and conservative surgery for soft tissue sarcomas.

G. Westbury, C. Harmer, M. Robinson, 1992, Clinical oncology (Royal College of Radiologists (Great Britain)).

An open label, phase II, multicenter, study to evaluate the efficacy and safety of pertuzumab (P) in chemotherapy naïve patients (pts) with hormone refractory prostate cancer (HRPC)

C. Parker, J. Bono, C. Sternberg, 2005 .

The use of bisphosphonates in prostatic cancer.

D. Dearnaley, M. Mason, J. Glaholm, 1994, Clinical oncology (Royal College of Radiologists (Great Britain)).

Use of carboplatin in germ cell tumors of the testis.

A. Horwich, D. Dearnaley, M. Mason, 1992, Seminars in oncology.

The effect of carboplatin on renal function in patients with metastatic germ cell tumours.

A. Horwich, J. Nicholls, M. Mason, 1991, British Journal of Cancer.

Effectiveness of carboplatin, etoposide, and bleomycin combination chemotherapy in good-prognosis metastatic testicular nonseminomatous germ cell tumors.

D. Dearnaley, A. Horwich, J. Nicholls, 1991, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

The Current Status of Radiotherapy in the Management of Germ Cell Tumours

M. Mason, 2002 .

A randomised comparison of single agent carboplatin with radiotherapy in the adjuvant treatment of stage I seminoma of the testis, following orchidectomy: MRC TE19/EORTC 30982.

G. Rustin, G. Mead, P. Ell, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A phase II trial of TIP (paclitaxel, ifosfamide and cisplatin) given as second-line (post-BEP) salvage chemotherapy for patients with metastatic germ cell cancer: a medical research council trial

R. Huddart, G. Rustin, G. Mead, 2005, British Journal of Cancer.

The activity of single-agent carboplatin in advanced seminoma.

A. Horwich, R. A’Hern, J. Nicholls, 1992, European journal of cancer.

Early closure of a randomized controlled trial of three treatment approaches to early localised prostate cancer: the MRC PR06 trial

Srinivasan, P. Fayers, M. Sydes, 2004, BJU international.

An unusual late relapse of metastatic non-seminomatous germ cell tumour.

F. McKinna, M. Mason, P. N. Matthews, 1994, Clinical oncology (Royal College of Radiologists (Great Britain)).

Hormonal impact of the 17α-hydroxylase/C17,20-lyase inhibitor abiraterone acetate (CB7630) in patients with prostate cancer

I Judson, M. Dowsett, D. Dearnaley, 2004, British Journal of Cancer.

Risk of second brain tumour after conservative surgery and radiotherapy for pituitary adenoma.

J. Bliss, S. Ashley, D. Ford, 1992, BMJ.

Inguinal and iliac lymph node involvement in germ cell tumours of the testis: implications for radiological investigation and for therapy.

A. Horwich, M. Mason, J. Olliff, 1991, Clinical oncology (Royal College of Radiologists (Great Britain)).

Treatment of stage I seminoma: more choices, more dilemmas.

M. Mason, W. Jones, 1997, Clinical oncology (Royal College of Radiologists (Great Britain)).

Intensive induction chemotherapy with CBOP/BEP in patients with poor prognosis germ cell tumors.

D. Dearnaley, A. Horwich, R. Huddart, 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Intens ive Induct ion Chemotherapy With CBOP / BEP in Pat ients With Poor Prognosis Germ Cel l Tumors

S. Fosså, D. Dearnaley, A. Horwich, 2003 .

Intravesical bacillus Calmette‐Guérin is superior to mitomycin C in reducing tumour recurrence in high‐risk superficial bladder cancer: a meta‐analysis of randomized trials

T. Wilt, M. Mason, H. Kynaston, 2004, BJU international.

The effects of induced hypogonadism on arterial stiffness, body composition, and metabolic parameters in males with prostate cancer.

M. Parmar, S. Bennett, J. Cockcroft, 2001, The Journal of clinical endocrinology and metabolism.

Thrombocytopenia with absent radii (TAR) syndrome: a new increased cellular radiosensitivity syndrome.

R. Wurm, J. Peacock, N. Burnet, 1995, Clinical oncology (Royal College of Radiologists (Great Britain)).

Radiotherapy versus single-dose carboplatin in adjuvant treatment of stage I seminoma: a randomised trial

G. Rustin, R. Coleman, R. Wit, 2005, The Lancet.

Intracardiac metastases from germ cell tumours--an unusual but important site of metastasis.

A. Horwich, D. Pickuth, P. Goldstraw, 1992, The British journal of radiology.

Factors affecting presentation and delay in patients with testicular cancer: results of a qualitative study

M. Mason, E. Roberts, P. Gascoigne, 1999, Psycho-oncology.

The prevalence and predictors of psychological distress in patients with early localized prostate cancer

M. Mason, H. Kynaston, D. Jones, 2002, BJU international.

Clinical oncologists favour radical radiotherapy for localized prostate cancer: a questionnaire survey

C. L. Hanna, M. Mason, J. Barber, 2002, BJU international.

Specialist gynaecologists and survival outcome in ovarian cancer: a Scottish national study of 1866 patients

D. Hole, E. Junor, M. Mason, 1999, British journal of obstetrics and gynaecology.

A phase II trial of TIP (paclitaxel, ifosfamide and cisplatin) given as second-line (post-BEP) salvage chemotherapy for patients with metastatic germ cell cancer: a medical research council trial

R. Huddart, G. Rustin, G. Mead, 2005, British Journal of Cancer.